Barry Rosenbloom - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Barry Rosenbloom

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

The New England Journal of Medicine|April 16, 2010

A randomized study of alglucosidase alfa in late-onset Pompe's diseaseAns T van der Ploeg, Paula R Clemens, Deyanira Corzo, et al.

Blood Cells, Molecules & Diseases|April 28, 2019

Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1Pramod K Mistry, Manisha Balwani, Hagit N Baris, et al.

Blood Cells, Molecules & Diseases|April 23, 2018

Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1Pramod K Mistry, Manisha Balwani, Hagit N Baris, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

The New England Journal of Medicine|April 16, 2010

A randomized study of alglucosidase alfa in late-onset Pompe's diseaseAns T van der Ploeg, Paula R Clemens, Deyanira Corzo, et al.

Blood Cells, Molecules & Diseases|April 28, 2019

Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1Pramod K Mistry, Manisha Balwani, Hagit N Baris, et al.

Blood Cells, Molecules & Diseases|April 23, 2018

Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1Pramod K Mistry, Manisha Balwani, Hagit N Baris, et al.

Pageof 2